Author Correction: Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection

Nat Immunol. 2020 Mar;21(3):354. doi: 10.1038/s41590-019-0560-5.

Estefania Fernandez¹, Wanwisa Dejnirattisai², Bin Cao³, Suzanne M Scheaffer³, Piyada Supasa², Wiyada Wongwiwat², Prabagaran Esakky³, Andrea Drury³, Juthathip Mongkolsapaya^{2

4}, Kelle H Moley³, Indira U Mysorekar^{1

3}, Gavin R Screaton^{5

6}, Michael S Diamond^{7

8

9

10}

¹ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
² Division of Immunology and Inflammation, Department of Medicine, Hammersmith Campus, Imperial College, London, UK.
³ Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA.
⁴ Dengue Hemorrhagic Fever Research Unit, Office for Research and Development, Siriraj Hospital, Faculty of Medicine, Mahidol University, Bangkok, Thailand.
⁵ Division of Immunology and Inflammation, Department of Medicine, Hammersmith Campus, Imperial College, London, UK. g.screaton@imperial.ac.uk.
⁶ Medical Sciences Divisional Office, University of Oxford, John Radcliffe Hospital, Oxford, UK. g.screaton@imperial.ac.uk.
⁷ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. diamond@wusm.wustl.edu.
⁸ Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. diamond@wusm.wustl.edu.
⁹ Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA. diamond@wusm.wustl.edu.
¹⁰ Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA. diamond@wusm.wustl.edu.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.